BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2228343)

  • 1. Ranitidine in children with peptic ulcer and patients with pancreatic cystic fibrosis.
    Scorza A; Conti-Nibali S; Sferlazzas C; Saitta G; Tedeschi A
    Int J Clin Pharmacol Res; 1990; 10(3):179-82. PubMed ID: 2228343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.
    Brodzicki J; Trawińska-Bartnicka M; Korzon M
    Med Sci Monit; 2002 Jul; 8(7):CR529-37. PubMed ID: 12118204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do H2 receptor antagonists have a therapeutic role in childhood?
    Kelly DA
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ranitidine VUFB in the treatment of peptic ulcer].
    Steinigerová J; Kratochvíl J
    Vnitr Lek; 1991 Feb; 37(2):135-40. PubMed ID: 2021072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ranitidine and duration of gastric pH >4.0 in infants with persisting reflux symptoms.
    Salvatore S; Hauser B; Salvatoni A; Vandenplas Y
    Acta Paediatr; 2006 Feb; 95(2):176-81. PubMed ID: 16449023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acid inhibition on Campylobacter pylori.
    Blanco M; Pajares JM; Jimenez ML; Lopez-Brea M
    Scand J Gastroenterol Suppl; 1988; 142():107-9. PubMed ID: 2901784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
    Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
    Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of H2-receptor antagonists in children.
    Dimand RJ
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB; Friedman LS; Isselbacher KJ
    N Engl J Med; 1983 Dec; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Primary peptic ulcer in infancy and childhood. Personal experience].
    Lama Moré R; Prieto Bozano G; Carrasco Gandía S; Miralles Adarraga T; Polanco Allúe I
    An Esp Pediatr; 1990 Aug; 33(2):113-6. PubMed ID: 2275489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acid-related diseases of the gastrointestinal tract. Observations in patients receiving a single evening dose of 300 mg ranitidine].
    Sewing KF; Franz E
    Fortschr Med; 1992 Mar; 110(7):114-6. PubMed ID: 1559647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori infection in childhood: results of management with ranitidine bismuth citrate plus amoxicillin and tinidazole.
    Nijevitch AA; Farztdinov KM; Sataev VU; Khasanov RSh ; Katayev VA; Khusnutdinov SM; Akhunov ED; Kazykhanov NS
    J Gastroenterol Hepatol; 2000 Nov; 15(11):1243-50. PubMed ID: 11129216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Tam YH; Yeung CK; Lee KH
    Aliment Pharmacol Ther; 2006 Jul; 24(1):81-6. PubMed ID: 16803605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for peptic ulcer disease.
    Voirin J
    Am Fam Physician; 1984 Dec; 30(6):154-9. PubMed ID: 6095630
    [No Abstract]   [Full Text] [Related]  

  • 19. Ranitidine: a pilot study in Japan.
    Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
    Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.